Rutherford Crossing Dialysis is a medicare approved dialysis facility center in Winchester, Virginia and it has 13 dialysis stations. It is located in Frederick county at 141 Market Street, Winchester, VA, 22603. You can reach out to the office of Rutherford Crossing Dialysis at (540) 665-5169. This dialysis clinic is managed and/or owned by Davita. Rutherford Crossing Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 492704 and it accepts patients under medicare ESRD program.
Name | Rutherford Crossing Dialysis |
---|---|
Location | 141 Market Street, Winchester, Virginia |
No. of Dialysis Stations | 13 |
Medicare ID | 492704 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
141 Market Street, Winchester, Virginia, 22603 | |
(540) 665-5169 | |
Not Available |
News Archive
News outlets report that lawmakers are returning to work after a two-week recess, during which they faced emotional challenges from constituents regarding the deficit and the nation's entitlement programs.
Labopharm Inc. today announced that the underwriters for the recently announced public offering of newly issued units have exercised in full their over-allotment option to purchase an additional 1,764,706 units. The 1,764,706 additional units are being sold at the public offering price of US$1.70 per unit and will bring the total number of units issued under the public offering to 13,529,412 units.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Bed bugs are an increasingly common pest that necessitates extensive decontamination of homes. However, researchers from Lund and Sundsvall in Sweden have now discovered that young bed bugs produce a smell that repels other bed bugs. It is hoped that these findings could contribute to more effective control of the blood-sucking insects.
Mapping the global distribution of toxic pollution alongside the effects of climate change shows the same countries are most vulnerable to both.
› Verified 7 days ago
NPI Number | 1881047637 |
Organization Name | Rutherford Crossing Dialysis |
Doing Business As | Total Renal Care, Inc. |
Address | 141 Market St Winchester, Virginia, 22603 |
Phone Number | (540) 665-5169 |
News Archive
News outlets report that lawmakers are returning to work after a two-week recess, during which they faced emotional challenges from constituents regarding the deficit and the nation's entitlement programs.
Labopharm Inc. today announced that the underwriters for the recently announced public offering of newly issued units have exercised in full their over-allotment option to purchase an additional 1,764,706 units. The 1,764,706 additional units are being sold at the public offering price of US$1.70 per unit and will bring the total number of units issued under the public offering to 13,529,412 units.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Bed bugs are an increasingly common pest that necessitates extensive decontamination of homes. However, researchers from Lund and Sundsvall in Sweden have now discovered that young bed bugs produce a smell that repels other bed bugs. It is hoped that these findings could contribute to more effective control of the blood-sucking insects.
Mapping the global distribution of toxic pollution alongside the effects of climate change shows the same countries are most vulnerable to both.
› Verified 7 days ago
Dialysis patients with Hemoglobin data | 10 |
News Archive
News outlets report that lawmakers are returning to work after a two-week recess, during which they faced emotional challenges from constituents regarding the deficit and the nation's entitlement programs.
Labopharm Inc. today announced that the underwriters for the recently announced public offering of newly issued units have exercised in full their over-allotment option to purchase an additional 1,764,706 units. The 1,764,706 additional units are being sold at the public offering price of US$1.70 per unit and will bring the total number of units issued under the public offering to 13,529,412 units.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Bed bugs are an increasingly common pest that necessitates extensive decontamination of homes. However, researchers from Lund and Sundsvall in Sweden have now discovered that young bed bugs produce a smell that repels other bed bugs. It is hoped that these findings could contribute to more effective control of the blood-sucking insects.
Mapping the global distribution of toxic pollution alongside the effects of climate change shows the same countries are most vulnerable to both.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 22 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 104 |
Percentage of adult patients getting regular hemodialysis at the center | 94 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
News outlets report that lawmakers are returning to work after a two-week recess, during which they faced emotional challenges from constituents regarding the deficit and the nation's entitlement programs.
Labopharm Inc. today announced that the underwriters for the recently announced public offering of newly issued units have exercised in full their over-allotment option to purchase an additional 1,764,706 units. The 1,764,706 additional units are being sold at the public offering price of US$1.70 per unit and will bring the total number of units issued under the public offering to 13,529,412 units.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Bed bugs are an increasingly common pest that necessitates extensive decontamination of homes. However, researchers from Lund and Sundsvall in Sweden have now discovered that young bed bugs produce a smell that repels other bed bugs. It is hoped that these findings could contribute to more effective control of the blood-sucking insects.
Mapping the global distribution of toxic pollution alongside the effects of climate change shows the same countries are most vulnerable to both.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Rutherford Crossing Dialysis with elevated calcium levels.
Patients with hypercalcemia | 23 |
Hypercalcemia patient months | 108 |
Patients with Serumphosphor | 28 |
Patients with Serumphosphor less than 3.5 mg/dL | 9 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 41 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 13 |
Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
News outlets report that lawmakers are returning to work after a two-week recess, during which they faced emotional challenges from constituents regarding the deficit and the nation's entitlement programs.
Labopharm Inc. today announced that the underwriters for the recently announced public offering of newly issued units have exercised in full their over-allotment option to purchase an additional 1,764,706 units. The 1,764,706 additional units are being sold at the public offering price of US$1.70 per unit and will bring the total number of units issued under the public offering to 13,529,412 units.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Bed bugs are an increasingly common pest that necessitates extensive decontamination of homes. However, researchers from Lund and Sundsvall in Sweden have now discovered that young bed bugs produce a smell that repels other bed bugs. It is hoped that these findings could contribute to more effective control of the blood-sucking insects.
Mapping the global distribution of toxic pollution alongside the effects of climate change shows the same countries are most vulnerable to both.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 27 |
Patient months included in arterial venous fistula and catheter summaries | 118 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 81 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
News outlets report that lawmakers are returning to work after a two-week recess, during which they faced emotional challenges from constituents regarding the deficit and the nation's entitlement programs.
Labopharm Inc. today announced that the underwriters for the recently announced public offering of newly issued units have exercised in full their over-allotment option to purchase an additional 1,764,706 units. The 1,764,706 additional units are being sold at the public offering price of US$1.70 per unit and will bring the total number of units issued under the public offering to 13,529,412 units.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Bed bugs are an increasingly common pest that necessitates extensive decontamination of homes. However, researchers from Lund and Sundsvall in Sweden have now discovered that young bed bugs produce a smell that repels other bed bugs. It is hoped that these findings could contribute to more effective control of the blood-sucking insects.
Mapping the global distribution of toxic pollution alongside the effects of climate change shows the same countries are most vulnerable to both.
› Verified 7 days ago